APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cyclodextrin in Pharma

Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by α-1,4 glycosidic bonds. Cyclodextrins are produced from starch by enzymatic conversion. They are used in food, pharmaceutical, drug delivery, and chemical industries, as well as agriculture and environmental engineering.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by α-1,4 glycosidic bonds. Cyclodextrins are produced from starch by enzymatic conversion. They are used in food, pharmaceutical, drug delivery, and chemical industries, as well as agriculture and environmental engineering.

Selected research

Industry Growth & Trends

Global Cyclodextrin in Pharma Industry Growth and Trends Forecast to 2032

Report ID 173252520129 December 2025101 pages

Choose your research edition.

Industry ResearchCyclodextrin in Pharma Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclodextrin in Pharma Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Cyclodextrin in Pharma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclodextrin in Pharma Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclodextrin in Pharma Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by α-1,4 glycosidic bonds. Cyclodextrins are produced from starch by enzymatic conversion. They are used in food, pharmaceutical, drug delivery, and chemical industries, as well as agriculture and environmental engineering.

Global key manufacturers of cyclodextrin in pharma include Wacker, Ensuiko Sugar Refining, Ashland, etc. Global top 3 manufacturers hold a share above 60%. Europe and North America are the major producing regions in the world, followed by China and Japan. In terms of application, the product is most widely used in tablets and capsules, followed by injectables.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Cyclodextrin in Pharma market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cyclodextrin in Pharma market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cyclodextrin in Pharma market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cyclodextrin in Pharma.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cyclodextrin in Pharma market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cyclodextrin in Pharma Market by Company

Wacker

Ensuiko Sugar Refining

Nihon Shokuhin Kako

Roquette

Ashland

Shandong Xinda

Yunan Yongguang

Qufu Tianli

Zibo Qianhui

Jiangsu Fengyuan

Mengzhou Huaxing

Mengzhou Hongji

Cyclodextrin in Pharma Segment by Type

Alpha-Cyclodextrin in Pharma

Beta-Cyclodextrin in Pharma

Gamma-Cyclodextrin in Pharma

CD Derivatives

Cyclodextrin in Pharma Segment by Application

Tablets and Capsules

Injectables

Cyclodextrin in Pharma Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclodextrin in Pharma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclodextrin in Pharma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclodextrin in Pharma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cyclodextrin in Pharma manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cyclodextrin in Pharma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Alpha-Cyclodextrin in Pharma Table 2. Major Company of Beta-Cyclodextrin in Pharma Table 3. Major Company of Gamma-Cyclodextrin in Pharma Table 4. Major Company of CD Derivatives Table 5. Global Cyclodextrin in Pharma Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Cyclodextrin in Pharma Sales by Type (2021-2026) & (MT) Table 7. Global Cyclodextrin in Pharma Sales Market Share in Volume by Type (2021-2026) Table 8. Global Cyclodextrin in Pharma Sales by Type (2021-2026) & (US$ Million) Table 9. Global Cyclodextrin in Pharma Sales Market Share in Value by Type (2021-2026) Table 10. Global Cyclodextrin in Pharma Price by Type (2021-2026) & (USD/MT) Table 11. Global Cyclodextrin in Pharma Sales by Type (2027-2032) & (MT) Table 12. Global Cyclodextrin in Pharma Sales Market Share in Volume by Type (2027-2032) Table 13. Global Cyclodextrin in Pharma Sales by Type (2027-2032) & (US$ Million) Table 14. Global Cyclodextrin in Pharma Sales Market Share in Value by Type (2027-2032) Table 15. Global Cyclodextrin in Pharma Price by Type (2027-2032) & (USD/MT) Table 16. North America Cyclodextrin in Pharma Sales by Type (2021-2026) & (MT) Table 17. North America Cyclodextrin in Pharma Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Cyclodextrin in Pharma Sales by Type (2021-2026) & (MT) Table 19. Europe Cyclodextrin in Pharma Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Cyclodextrin in Pharma Sales by Type (2021-2026) & (MT) Table 21. Asia-Pacific Cyclodextrin in Pharma Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Cyclodextrin in Pharma Sales by Type (2021-2026) & (MT) Table 23. Latin America Cyclodextrin in Pharma Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Cyclodextrin in Pharma Sales by Type (2021-2026) & (MT) Table 25. Middle East and Africa Cyclodextrin in Pharma Sales by Type (2021-2026) & (US$ Million) Table 26. Cyclodextrin in Pharma Industry Trends Table 27. Cyclodextrin in Pharma Industry Drivers Table 28. Cyclodextrin in Pharma Industry Opportunities and Challenges Table 29. Cyclodextrin in Pharma Industry Restraints Table 30. Global Cyclodextrin in Pharma Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Cyclodextrin in Pharma Revenue Market Share by Company (2021-2026) Table 32. Global Cyclodextrin in Pharma Sales by Company (2021-2026) & (MT) Table 33. Global Cyclodextrin in Pharma Sales Share by Company (2021-2026) Table 34. Global Cyclodextrin in Pharma Market Price by Company (2021-2026) & (USD/MT) Table 35. Global Cyclodextrin in Pharma Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Cyclodextrin in Pharma Major Company Production Sites and Headquarters Table 37. Global Cyclodextrin in Pharma Company, Product Type & Application Table 38. Global Cyclodextrin in Pharma Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Cyclodextrin in Pharma by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Cyclodextrin in Pharma Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Cyclodextrin in Pharma Sales by Region (2021-2026) & (MT) Table 43. Global Cyclodextrin in Pharma Sales Market Share in Volume by Region (2021-2026) Table 44. Global Cyclodextrin in Pharma Sales by Region (2021-2026) & (US$ Million) Table 45. Global Cyclodextrin in Pharma Sales Market Share in Value by Region (2021-2026) Table 46. Global Cyclodextrin in Pharma Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 47. Global Cyclodextrin in Pharma Sales by Region (2027-2032) & (MT) Table 48. Global Cyclodextrin in Pharma Sales Market Share in Volume by Region (2027-2032) Table 49. Global Cyclodextrin in Pharma Sales by Region (2027-2032) & (US$ Million) Table 50. Global Cyclodextrin in Pharma Sales Market Share in Value by Region (2027-2032) Table 51. Global Cyclodextrin in Pharma Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2027-2032) Table 52. Global Cyclodextrin in Pharma Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Cyclodextrin in Pharma Sales by Application (2021-2026) & (MT) Table 54. Global Cyclodextrin in Pharma Sales Market Share in Volume by Application (2021-2026) Table 55. Global Cyclodextrin in Pharma Sales by Application (2021-2026) & (US$ Million) Table 56. Global Cyclodextrin in Pharma Sales Market Share in Value by Application (2021-2026) Table 57. Global Cyclodextrin in Pharma Price by Application (2021-2026) & (USD/MT) Table 58. Global Cyclodextrin in Pharma Sales by Application (2027-2032) & (MT) Table 59. Global Cyclodextrin in Pharma Sales Market Share in Volume by Application (2027-2032) Table 60. Global Cyclodextrin in Pharma Sales by Application (2027-2032) & (US$ Million) Table 61. Global Cyclodextrin in Pharma Sales Market Share in Value by Application (2027-2032) Table 62. Global Cyclodextrin in Pharma Price by Application (2027-2032) & (USD/MT) Table 63. North America Cyclodextrin in Pharma Sales by Application (2021-2026) & (MT) Table 64. North America Cyclodextrin in Pharma Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Cyclodextrin in Pharma Sales by Application (2021-2026) & (MT) Table 66. Europe Cyclodextrin in Pharma Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Cyclodextrin in Pharma Sales by Application (2021-2026) & (MT) Table 68. Asia-Pacific Cyclodextrin in Pharma Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Cyclodextrin in Pharma Sales by Application (2021-2026) & (MT) Table 70. Latin America Cyclodextrin in Pharma Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Cyclodextrin in Pharma Sales by Application (2021-2026) & (MT) Table 72. Middle East and Africa Cyclodextrin in Pharma Sales by Application (2021-2026) & (US$ Million) Table 73. Wacker Company Information Table 74. Wacker Business Overview Table 75. Wacker Cyclodextrin in Pharma Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 76. Wacker Cyclodextrin in Pharma Product Portfolio Table 77. Wacker Recent Development Table 78. Ensuiko Sugar Refining Company Information Table 79. Ensuiko Sugar Refining Business Overview Table 80. Ensuiko Sugar Refining Cyclodextrin in Pharma Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 81. Ensuiko Sugar Refining Cyclodextrin in Pharma Product Portfolio Table 82. Ensuiko Sugar Refining Recent Development Table 83. Nihon Shokuhin Kako Company Information Table 84. Nihon Shokuhin Kako Business Overview Table 85. Nihon Shokuhin Kako Cyclodextrin in Pharma Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 86. Nihon Shokuhin Kako Cyclodextrin in Pharma Product Portfolio Table 87. Nihon Shokuhin Kako Recent Development Table 88. Roquette Company Information Table 89. Roquette Business Overview Table 90. Roquette Cyclodextrin in Pharma Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 91. Roquette Cyclodextrin in Pharma Product Portfolio Table 92. Roquette Recent Development Table 93. Ashland Company Information Table 94. Ashland Business Overview Table 95. Ashland Cyclodextrin in Pharma Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 96. Ashland Cyclodextrin in Pharma Product Portfolio Table 97. Ashland Recent Development Table 98. Shandong Xinda Company Information Table 99. Shandong Xinda Business Overview Table 100. Shandong Xinda Cyclodextrin in Pharma Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 101. Shandong Xinda Cyclodextrin in Pharma Product Portfolio Table 102. Shandong Xinda Recent Development Table 103. Yunan Yongguang Company Information Table 104. Yunan Yongguang Business Overview Table 105. Yunan Yongguang Cyclodextrin in Pharma Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 106. Yunan Yongguang Cyclodextrin in Pharma Product Portfolio Table 107. Yunan Yongguang Recent Development Table 108. Qufu Tianli Company Information Table 109. Qufu Tianli Business Overview Table 110. Qufu Tianli Cyclodextrin in Pharma Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 111. Qufu Tianli Cyclodextrin in Pharma Product Portfolio Table 112. Qufu Tianli Recent Development Table 113. Zibo Qianhui Company Information Table 114. Zibo Qianhui Business Overview Table 115. Zibo Qianhui Cyclodextrin in Pharma Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 116. Zibo Qianhui Cyclodextrin in Pharma Product Portfolio Table 117. Zibo Qianhui Recent Development Table 118. Jiangsu Fengyuan Company Information Table 119. Jiangsu Fengyuan Business Overview Table 120. Jiangsu Fengyuan Cyclodextrin in Pharma Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 121. Jiangsu Fengyuan Cyclodextrin in Pharma Product Portfolio Table 122. Jiangsu Fengyuan Recent Development Table 123. Mengzhou Huaxing Company Information Table 124. Mengzhou Huaxing Business Overview Table 125. Mengzhou Huaxing Cyclodextrin in Pharma Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 126. Mengzhou Huaxing Cyclodextrin in Pharma Product Portfolio Table 127. Mengzhou Huaxing Recent Development Table 128. Mengzhou Hongji Company Information Table 129. Mengzhou Hongji Business Overview Table 130. Mengzhou Hongji Cyclodextrin in Pharma Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 131. Mengzhou Hongji Cyclodextrin in Pharma Product Portfolio Table 132. Mengzhou Hongji Recent Development Table 133. North America Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 134. North America Cyclodextrin in Pharma Sales by Country (2021-2026) & (MT) Table 135. North America Cyclodextrin in Pharma Sales Market Share by Country (2021-2026) Table 136. North America Cyclodextrin in Pharma Sales Forecast by Country (2027-2032) & (MT) Table 137. North America Cyclodextrin in Pharma Sales Market Share Forecast by Country (2027-2032) Table 138. North America Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Cyclodextrin in Pharma Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Cyclodextrin in Pharma Market Share by Country (2021-2026) Table 141. North America Cyclodextrin in Pharma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Cyclodextrin in Pharma Market Share Forecast by Country (2027-2032) Table 143. Europe Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 144. Europe Cyclodextrin in Pharma Sales by Country (2021-2026) & (MT) Table 145. Europe Cyclodextrin in Pharma Sales Market Share by Country (2021-2026) Table 146. Europe Cyclodextrin in Pharma Sales Forecast by Country (2027-2032) & (MT) Table 147. Europe Cyclodextrin in Pharma Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Cyclodextrin in Pharma Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Cyclodextrin in Pharma Market Share by Country (2021-2026) Table 151. Europe Cyclodextrin in Pharma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Cyclodextrin in Pharma Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Cyclodextrin in Pharma Sales by Country (2021-2026) & (MT) Table 155. Asia-Pacific Cyclodextrin in Pharma Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Cyclodextrin in Pharma Sales Forecast by Country (2027-2032) & (MT) Table 157. Asia-Pacific Cyclodextrin in Pharma Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Cyclodextrin in Pharma Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Cyclodextrin in Pharma Market Share by Country (2021-2026) Table 161. Asia-Pacific Cyclodextrin in Pharma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Cyclodextrin in Pharma Market Share Forecast by Country (2027-2032) Table 163. Latin America Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 164. Latin America Cyclodextrin in Pharma Sales by Country (2021-2026) & (MT) Table 165. Latin America Cyclodextrin in Pharma Sales Market Share by Country (2021-2026) Table 166. Latin America Cyclodextrin in Pharma Sales Forecast by Country (2027-2032) & (MT) Table 167. Latin America Cyclodextrin in Pharma Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Cyclodextrin in Pharma Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Cyclodextrin in Pharma Market Share by Country (2021-2026) Table 171. Latin America Cyclodextrin in Pharma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Cyclodextrin in Pharma Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Cyclodextrin in Pharma Sales by Country (2021-2026) & (MT) Table 175. Middle East and Africa Cyclodextrin in Pharma Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Cyclodextrin in Pharma Sales Forecast by Country (2027-2032) & (MT) Table 177. Middle East and Africa Cyclodextrin in Pharma Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Cyclodextrin in Pharma Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Cyclodextrin in Pharma Market Share by Country (2021-2026) Table 181. Middle East and Africa Cyclodextrin in Pharma Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Cyclodextrin in Pharma Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Cyclodextrin in Pharma Distributors List Table 186. Cyclodextrin in Pharma Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Cyclodextrin in Pharma Image Figure 2. Global Cyclodextrin in Pharma Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyclodextrin in Pharma Market Size (2021-2032) & (US$ Million) Figure 4. Global Cyclodextrin in Pharma Sales (2021-2032) & (MT) Figure 5. Alpha-Cyclodextrin in Pharma Image Figure 6. Global Alpha-Cyclodextrin in Pharma Sales YoY Growth (2021-2032) & (MT) Figure 7. Beta-Cyclodextrin in Pharma Image Figure 8. Global Beta-Cyclodextrin in Pharma Sales YoY Growth (2021-2032) & (MT) Figure 9. Gamma-Cyclodextrin in Pharma Image Figure 10. Global Gamma-Cyclodextrin in Pharma Sales YoY Growth (2021-2032) & (MT) Figure 11. CD Derivatives Image Figure 12. Global CD Derivatives Sales YoY Growth (2021-2032) & (MT) Figure 13. Global Cyclodextrin in Pharma Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Cyclodextrin in Pharma Market Share by Type 2025 VS 2032 Figure 15. North America Cyclodextrin in Pharma Sales Market Share in Volume by Type in 2025 Figure 16. North America Cyclodextrin in Pharma Sales Market Share in Value by Type in 2025 Figure 17. Europe Cyclodextrin in Pharma Sales Market Share in Volume by Type in 2025 Figure 18. Europe Cyclodextrin in Pharma Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Cyclodextrin in Pharma Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Cyclodextrin in Pharma Sales Market Share in Value by Type in 2025 Figure 21. Latin America Cyclodextrin in Pharma Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Cyclodextrin in Pharma Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Cyclodextrin in Pharma Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Cyclodextrin in Pharma Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Cyclodextrin in Pharma Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Tablets and Capsules Image Figure 28. Global Tablets and Capsules Sales YoY Growth (2021-2032) & (MT) Figure 29. Injectables Image Figure 30. Global Injectables Sales YoY Growth (2021-2032) & (MT) Figure 31. Global Cyclodextrin in Pharma Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cyclodextrin in Pharma Market Share by Application 2025 VS 2032 Figure 33. North America Cyclodextrin in Pharma Sales Market Share in Volume by Application in 2025 Figure 34. North America Cyclodextrin in Pharma Sales Market Share in Value by Application in 2025 Figure 35. Europe Cyclodextrin in Pharma Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cyclodextrin in Pharma Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cyclodextrin in Pharma Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cyclodextrin in Pharma Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cyclodextrin in Pharma Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cyclodextrin in Pharma Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cyclodextrin in Pharma Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cyclodextrin in Pharma Sales Market Share in Value by Application in 2025 Figure 43. North America Cyclodextrin in Pharma Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 44. North America Cyclodextrin in Pharma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cyclodextrin in Pharma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cyclodextrin in Pharma Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cyclodextrin in Pharma Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 48. Europe Cyclodextrin in Pharma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cyclodextrin in Pharma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cyclodextrin in Pharma Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cyclodextrin in Pharma Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 52. Asia-Pacific Cyclodextrin in Pharma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cyclodextrin in Pharma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cyclodextrin in Pharma Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cyclodextrin in Pharma Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 56. Latin America Cyclodextrin in Pharma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cyclodextrin in Pharma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cyclodextrin in Pharma Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cyclodextrin in Pharma Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 60. Middle East and Africa Cyclodextrin in Pharma Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cyclodextrin in Pharma Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cyclodextrin in Pharma Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cyclodextrin in Pharma Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cyclodextrin in Pharma Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Alpha-Cyclodextrin in Pharma
  • Beta-Cyclodextrin in Pharma
  • Gamma-Cyclodextrin in Pharma
  • CD Derivatives
Applications
  • Tablets and Capsules
  • Injectables
Companies covered
  • Wacker
  • Ensuiko Sugar Refining
  • Nihon Shokuhin Kako
  • Roquette
  • Ashland
  • Shandong Xinda
  • Yunan Yongguang
  • Qufu Tianli
  • Zibo Qianhui
  • Jiangsu Fengyuan
  • Mengzhou Huaxing
  • Mengzhou Hongji

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cyclodextrin in Pharma Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cyclodextrin in Pharma Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cyclodextrin in Pharma Market by Type
  6. 1.3.1 Alpha-Cyclodextrin in Pharma
  7. 1.3.2 Beta-Cyclodextrin in Pharma
  8. 1.3.3 Gamma-Cyclodextrin in Pharma
  9. 1.3.4 CD Derivatives
  10. 1.4 Global Cyclodextrin in Pharma Market Size by Type
  11. 1.4.1 Global Cyclodextrin in Pharma Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Cyclodextrin in Pharma Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Cyclodextrin in Pharma Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Cyclodextrin in Pharma Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Cyclodextrin in Pharma Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Cyclodextrin in Pharma Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Cyclodextrin in Pharma Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Cyclodextrin in Pharma Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cyclodextrin in Pharma Industry Trends
  2. 2.2 Cyclodextrin in Pharma Industry Drivers
  3. 2.3 Cyclodextrin in Pharma Industry Opportunities and Challenges
  4. 2.4 Cyclodextrin in Pharma Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cyclodextrin in Pharma Revenue (2021-2026)
  2. 3.2 Global Top Players by Cyclodextrin in Pharma Sales (2021-2026)
  3. 3.3 Global Top Players by Cyclodextrin in Pharma Price (2021-2026)
  4. 3.4 Global Cyclodextrin in Pharma Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cyclodextrin in Pharma Major Company Production Sites & Headquarters
  6. 3.6 Global Cyclodextrin in Pharma Company, Product Type & Application
  7. 3.7 Global Cyclodextrin in Pharma Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cyclodextrin in Pharma Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cyclodextrin in Pharma Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cyclodextrin in Pharma Tier 1, Tier 2, and Tier 3
4 Cyclodextrin in Pharma Regional Status and Outlook
  1. 4.1 Global Cyclodextrin in Pharma Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cyclodextrin in Pharma Historic Market Size by Region
  3. 4.2.1 Global Cyclodextrin in Pharma Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cyclodextrin in Pharma Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cyclodextrin in Pharma Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cyclodextrin in Pharma Forecasted Market Size by Region
  7. 4.3.1 Global Cyclodextrin in Pharma Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cyclodextrin in Pharma Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cyclodextrin in Pharma Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cyclodextrin in Pharma by Application
  1. 5.1 Cyclodextrin in Pharma Market by Application
  2. 5.1.1 Tablets and Capsules
  3. 5.1.2 Injectables
  4. 5.2 Global Cyclodextrin in Pharma Market Size by Application
  5. 5.2.1 Global Cyclodextrin in Pharma Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Cyclodextrin in Pharma Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Cyclodextrin in Pharma Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Cyclodextrin in Pharma Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Cyclodextrin in Pharma Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Cyclodextrin in Pharma Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Cyclodextrin in Pharma Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Cyclodextrin in Pharma Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wacker
  2. 6.1.1 Wacker Company Information
  3. 6.1.2 Wacker Business Overview
  4. 6.1.3 Wacker Cyclodextrin in Pharma Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wacker Cyclodextrin in Pharma Product Portfolio
  6. 6.1.5 Wacker Recent Developments
  7. 6.2 Ensuiko Sugar Refining
  8. 6.2.1 Ensuiko Sugar Refining Company Information
  9. 6.2.2 Ensuiko Sugar Refining Business Overview
  10. 6.2.3 Ensuiko Sugar Refining Cyclodextrin in Pharma Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ensuiko Sugar Refining Cyclodextrin in Pharma Product Portfolio
  12. 6.2.5 Ensuiko Sugar Refining Recent Developments
  13. 6.3 Nihon Shokuhin Kako
  14. 6.3.1 Nihon Shokuhin Kako Company Information
  15. 6.3.2 Nihon Shokuhin Kako Business Overview
  16. 6.3.3 Nihon Shokuhin Kako Cyclodextrin in Pharma Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Nihon Shokuhin Kako Cyclodextrin in Pharma Product Portfolio
  18. 6.3.5 Nihon Shokuhin Kako Recent Developments
  19. 6.4 Roquette
  20. 6.4.1 Roquette Company Information
  21. 6.4.2 Roquette Business Overview
  22. 6.4.3 Roquette Cyclodextrin in Pharma Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roquette Cyclodextrin in Pharma Product Portfolio
  24. 6.4.5 Roquette Recent Developments
  25. 6.5 Ashland
  26. 6.5.1 Ashland Company Information
  27. 6.5.2 Ashland Business Overview
  28. 6.5.3 Ashland Cyclodextrin in Pharma Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ashland Cyclodextrin in Pharma Product Portfolio
  30. 6.5.5 Ashland Recent Developments
  31. 6.6 Shandong Xinda
  32. 6.6.1 Shandong Xinda Company Information
  33. 6.6.2 Shandong Xinda Business Overview
  34. 6.6.3 Shandong Xinda Cyclodextrin in Pharma Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shandong Xinda Cyclodextrin in Pharma Product Portfolio
  36. 6.6.5 Shandong Xinda Recent Developments
  37. 6.7 Yunan Yongguang
  38. 6.7.1 Yunan Yongguang Company Information
  39. 6.7.2 Yunan Yongguang Business Overview
  40. 6.7.3 Yunan Yongguang Cyclodextrin in Pharma Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Yunan Yongguang Cyclodextrin in Pharma Product Portfolio
  42. 6.7.5 Yunan Yongguang Recent Developments
  43. 6.8 Qufu Tianli
  44. 6.8.1 Qufu Tianli Company Information
  45. 6.8.2 Qufu Tianli Business Overview
  46. 6.8.3 Qufu Tianli Cyclodextrin in Pharma Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Qufu Tianli Cyclodextrin in Pharma Product Portfolio
  48. 6.8.5 Qufu Tianli Recent Developments
  49. 6.9 Zibo Qianhui
  50. 6.9.1 Zibo Qianhui Company Information
  51. 6.9.2 Zibo Qianhui Business Overview
  52. 6.9.3 Zibo Qianhui Cyclodextrin in Pharma Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zibo Qianhui Cyclodextrin in Pharma Product Portfolio
  54. 6.9.5 Zibo Qianhui Recent Developments
  55. 6.10 Jiangsu Fengyuan
  56. 6.10.1 Jiangsu Fengyuan Company Information
  57. 6.10.2 Jiangsu Fengyuan Business Overview
  58. 6.10.3 Jiangsu Fengyuan Cyclodextrin in Pharma Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jiangsu Fengyuan Cyclodextrin in Pharma Product Portfolio
  60. 6.10.5 Jiangsu Fengyuan Recent Developments
  61. 6.11 Mengzhou Huaxing
  62. 6.11.1 Mengzhou Huaxing Company Information
  63. 6.11.2 Mengzhou Huaxing Business Overview
  64. 6.11.3 Mengzhou Huaxing Cyclodextrin in Pharma Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Mengzhou Huaxing Cyclodextrin in Pharma Product Portfolio
  66. 6.11.5 Mengzhou Huaxing Recent Developments
  67. 6.12 Mengzhou Hongji
  68. 6.12.1 Mengzhou Hongji Company Information
  69. 6.12.2 Mengzhou Hongji Business Overview
  70. 6.12.3 Mengzhou Hongji Cyclodextrin in Pharma Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Mengzhou Hongji Cyclodextrin in Pharma Product Portfolio
  72. 6.12.5 Mengzhou Hongji Recent Developments
7 North America by Country
  1. 7.1 North America Cyclodextrin in Pharma Sales by Country
  2. 7.1.1 North America Cyclodextrin in Pharma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cyclodextrin in Pharma Sales by Country (2021-2026)
  4. 7.1.3 North America Cyclodextrin in Pharma Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cyclodextrin in Pharma Market Size by Country
  6. 7.2.1 North America Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cyclodextrin in Pharma Market Size by Country (2021-2026)
  8. 7.2.3 North America Cyclodextrin in Pharma Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cyclodextrin in Pharma Sales by Country
  2. 8.1.1 Europe Cyclodextrin in Pharma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cyclodextrin in Pharma Sales by Country (2021-2026)
  4. 8.1.3 Europe Cyclodextrin in Pharma Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cyclodextrin in Pharma Market Size by Country
  6. 8.2.1 Europe Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cyclodextrin in Pharma Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cyclodextrin in Pharma Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cyclodextrin in Pharma Sales by Country
  2. 9.1.1 Asia-Pacific Cyclodextrin in Pharma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cyclodextrin in Pharma Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cyclodextrin in Pharma Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cyclodextrin in Pharma Market Size by Country
  6. 9.2.1 Asia-Pacific Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cyclodextrin in Pharma Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cyclodextrin in Pharma Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cyclodextrin in Pharma Sales by Country
  2. 10.1.1 South America Cyclodextrin in Pharma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cyclodextrin in Pharma Sales by Country (2021-2026)
  4. 10.1.3 South America Cyclodextrin in Pharma Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cyclodextrin in Pharma Market Size by Country
  6. 10.2.1 South America Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cyclodextrin in Pharma Market Size by Country (2021-2026)
  8. 10.2.3 South America Cyclodextrin in Pharma Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cyclodextrin in Pharma Sales by Country
  2. 11.1.1 Middle East and Africa Cyclodextrin in Pharma Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cyclodextrin in Pharma Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cyclodextrin in Pharma Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cyclodextrin in Pharma Market Size by Country
  6. 11.2.1 Middle East and Africa Cyclodextrin in Pharma Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cyclodextrin in Pharma Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cyclodextrin in Pharma Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cyclodextrin in Pharma Value Chain Analysis
  2. 12.1.1 Cyclodextrin in Pharma Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cyclodextrin in Pharma Production Mode & Process
  7. 12.2 Cyclodextrin in Pharma Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cyclodextrin in Pharma Distributors
  10. 12.2.3 Cyclodextrin in Pharma Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst